MedTrace Logo

Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma

NCT01382420 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 234

Last updated 2019-04-04

No results posted yet for this study

Summary

Objective:

To determine the metabolic effects of the adrenalectomy in subclinical Cushing's syndrome of adrenal incidentaloma.

Methods:

234 subclinical cushing syndrome and adrenal incidentaloma will be randomly assigned into two groups(e.g adrenalectomy group and conservative treatment group).

Conditions

  • Cushing Syndrome

Interventions

PROCEDURE

surgery

adrenalectomy

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER

  • Severance Hospital

    collaborator OTHER

  • Konkuk University Medical Center

    collaborator OTHER

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Jae Hyeon Kim · Samsung Medical Center

  • Jung-Min Koh · M.D, Ph.D

  • Kee-Ho Song · M.D, Ph.D.

  • Yumie Rhee · M.D, Ph.D.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2020-05-31
Completion
2024-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01382420 on ClinicalTrials.gov